Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1404-1405 (17 June), doi:10.1136/bmj.332.7555.1404
May be brought if patients die after clinical negligence
| The first 150 words of the full text of this article appear below. |
Until now, indictments for manslaughter founded on alleged gross negligence after the death of a patient in the United Kingdom have been brought against doctors rather than hospitals and NHS trusts. A recent groundbreaking legal decision indicates that this may change. A hospital or trust as an organisation could be incriminated in a charge following the death of a patient, and corporate manslaughter, or corporate killing, may emerge as a new threat for the NHS.
In the case in question a 31 year old man admitted to Southampton General Hospital in 2000 for a routine knee operation developed a bacterial infection which two senior house officers failed to diagnose and treat. The patient subsequently died of staphylococcal toxic shock syndrome. The doctors were convicted of gross negligence manslaughter at the Winchester Crown Court in 2003 and given suspended prison sentences. The NHS trust was prosecuted under section three of
Ash Samanta, consultant rheumatologist
Department of Rheumatology, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester LE1 5WW
(ash.samanta@uhl-tr.nhs.uk)
Jo Samanta, lecturer in law
De Montfort University, Leicester